Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes

Immunobiology

Volumn 220, Issue 3, 2015, Pages 406-413

  Liu, Ling ^a   Mu, Qingli ^a   Li, Weifeng ^a   Xing, Wei ^a   Zhang, Hailin ^a   Fan, Ting ^a   Yao, Huan ^a   He, Langchong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Anti inflammation; Histopathological changes; Isofraxidin; Nitric oxide; Nuclear factor B; Pro inflammatory cytokines

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOFRAXIDIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; MALE; MORTALITY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 84964283821     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.10.007     Document Type: Article

References (33)

1. Atreya I., Atreya R., Neurath M. NF-κB in inflammatory bowel disease. J. Intern. Med. 2008, 263:591-596.
2. Bours V., Bonizzi G., Bentires-Alj M., Bureau F., Piette J., Lekeux P., Merville M.-P. NF-κB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment. Toxicology 2000, 153:27-38.
3. Dyson A., Bryan N.S., Fernandez B.O., Garcia-Saura M.-F., Saijo F., Mongardon N., Rodriguez J., Singer M., Feelisch M. An integrated approach to assessing nitroso-redox balance in systemic inflammation. Free Radic. Biol. Med. 2011, 51:1137-1145.
4. Enomoto N., Takei Y., Hirose M., Kitamura T., Ikejima K., Sato N. Protective effect of thalidomide on endotoxin-induced liver injury. Alcohol. Clin. Exp. Res. 2003, 27:2S-6S.
5. Galanos C., Freudenberg M.A., Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:5939-5943.
6. Haveman J., Muller Kobold A., Cohen Tervaert J., Van den Berg A., Tulleken J., Kallenberg C., The T. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth. J. Med. 1999, 55:132-141.
7. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol. Res. 2001, 23:99-109.
8. Heinzel F.P., Rerko R.M., Ling P., Hakimi J., Schoenhaut D.S. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 1994, 62:4244-4249.
9. Jansen M.J., Hendriks T., Vogels M.T., van der Meer J.W., Goris R.J.A. Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. Crit. Care Med. 1996, 24:1196-1202.
10. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992, 258:593-597.
11. Kumins N.H., Hunt J., Gamelli R.L., Filkins J.P. Partial hepatectomy reduces the endotoxin-induced peak circulating level of tumor necrosis factor in rats. Shock 1996, 5:385-388.
12. Li W., Huang H., Niu X., Fan T., Mu Q., Li H. Protective effect of tetrahydrocoptisine against ethanol-induced gastric ulcer in mice. Toxicol. Appl. Pharmacol. 2013, 272:21-29.
13. Lin W.-W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117:1175-1183.
14. Liu S.F., Adcock I.M., Old R.W., Barnes P.J., Evans T.W. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysacchride treatment in vivo in the rat. Crit. Care Med. 1996, 24:1219-1225.
15. Liu S.F., Ye X., Malik A.B. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Exp. Med. 1997, 159:3976-3983.
16. Liu Y., Wu H., Nie Y.-C., Chen J.-L., Su W.-W., Li P.-B. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway. Int. Immunopharmacol. 2011, 11:1606-1612.
17. López-Bojórquez L.N., Dehesa A.Z., Reyes-Terán G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch. Med. Res. 2004, 35:465-479.
18. Mei X., Xu D., Xu S., Zheng Y., Xu S. Novel role of Zn (II)-curcumin in enhancing cell proliferation and adjusting proinflammatory cytokine-mediated oxidative damage of ethanol-induced acute gastric ulcers. Chem. Biol. Interact. 2012, 197:31-39.
19. Moncada S., Palmer R., Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
20. Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin. Infect. Dis. 2005, 41:S490-S497.
21. Nathan C., Xie Q.-W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
22. Niu X., Xing W., Li W., Fan T., Hu H., Li Y. Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway. Int. Immunopharmacol. 2012, 14(2):164-171.
23. Remick D.G., Bolgos G.R., Siddiqui J., Shin J., Nemzek J.A. Six at six: interleukin-6 measured 6h after the initiation of sepsis predicts mortality over 3 days. Shock 2002, 17:463-467.
24. Roth R.I., Su D., Child A.H., Wainwright N.R., Levin J. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia. J. Infect. Dis. 1998, 177:388-394.
25. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., Xie Q.-W., Nathan C., Gribble G.W., Sporn M.B. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 1998, 58:717-723.
26. Suzuki K., Tateda K., Matsumoto T., Gondaira F., Tsujimoto S., Yamaguchi K. Effects of interaction between Escherichia coli verotoxin and lipopolysaccharide on cytokine induction and lethality in mice. J. Med. Microbiol. 2000, 49:905-910.
27. Szabó C., Salzman A.L., Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett. 1995, 363:235-238.
28. Wang T., Zhang X., Li J.J. The role of NF-κB in the regulation of cell stress responses. Int. Immunopharmacol. 2002, 2:1509-1520.
29. Wu L.-C., Fan N.-C., Lin M.-H., Chu I.-R., Huang S.-J., Hu C.-Y., Han S.-Y. Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators. J. Agric. Food Chem. 2008, 56:2341-2349.
30. Xie Q., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
31. Xu W., Liu L., Charles I.G., Moncada S. Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response. Nat. Cell Biol. 2004, 6:1129-1134.
32. Yang F., Comtois A.S., Fang L., Hartman N.G., Blaise G. Nitric oxide-derived nitrate anion contributes to endotoxic shock and multiple organ injury/dysfunction*. Crit. Care Med. 2002, 30:650-657.
33. Yui J., Garcia-Lloret M., Wegmann T.G., Guilbert L. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994, 15:819-835.